Table 2.
Total Cases | Average Age | Male/Female | CSs | Progression in Stage | |
---|---|---|---|---|---|
COVID-19 patients | 31 | 61.35 | 19/12 | 11/31 (35.4%) positive | 11/31 |
Stage IIa | 10/31 (32%) | 56.4 | 5/5 | 10/10 (100%): negative | 0/10 |
Stage IIb | 21/31 (68%) | 63.7 | 14/7 | 10/21 (48%): negative | 0/10 |
Stage III | 11/21 (52%): positive | 11/11 (100%) |